EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 178 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $287,000 | -25.8% | 5,163 | -32.7% | 0.01% | -44.4% |
Q1 2019 | $387,000 | +19.1% | 7,670 | +26.1% | 0.01% | +125.0% |
Q4 2017 | $325,000 | -37.1% | 6,082 | -29.9% | 0.00% | -42.9% |
Q3 2017 | $517,000 | +69.5% | 8,670 | +124.2% | 0.01% | +75.0% |
Q2 2017 | $305,000 | +48.1% | 3,867 | -73.1% | 0.00% | -50.0% |
Q2 2014 | $206,000 | – | 14,363 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |